Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: A case series and literature review

Heart Rhythm

Volumn 9, Issue 12, 2012, Pages 1995-2000

  Márquez, Manlio F ^a   Bonny, Aimé ^b   Hernández Castillo, Eduardo ^a   De Sisti, Antonio ^b   Gómez Flores, Jorge ^a   Nava, Santiago ^a   Hidden Lucet, Françoise ^b   Iturralde, Pedro ^a   Cárdenas, Manuel ^a   Tonet, Joelci ^b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Arrhythmic storm; Brugada syndrome; Implantable cardioverter defibrillator; Quinidine; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

DIHYDROQUINIDINE; QUINIDINE SULFATE;

ADULT; BRUGADA SYNDROME; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW;

EID: 84870398579     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.08.027     Document Type: Article

References (35)

1. C. Antzelevitch, P. Brugada, M. Borggrefe et al. Brugada syndrome: report of the second consensus conference Heart Rhythm 2 2005 429 440
2. B. Belhassen, S. Viskin, R. Fish et al. Effects of electrophysiologic- guided therapy with class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome J Cardiovasc Electrophysiol 10 1999 1313 1315
3. B. Belhassen, A. Glick, S. Viskin Efficacy of quinidine in high-risk patients with Brugada syndrome Circulation 110 2004 1731 1737
4. J.S. Hermida, I. Denjoy, J. Clerc et al. Hydroquinidine therapy in Brugada syndrome J Am Coll Cardiol 43 2004 1853 1860
5. P. Maury, P. Couderc, M. Delay, S. Boveda, J. Brugada Electrical storm in Brugada syndrome successfully treated using isoprenaline Europace 6 2004 130 133
6. M.F. Márquez, J. Rivera Hermosillo AG, et al. Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope Pacing Clin Electrophysiol 28 2005 870 874
7. H.C. Shiue, V.G. Divakaran, N.M. Lakkis A case of Brugada syndrome presenting with incessant polymorphic ventricular tachycardia Clin Cardiol 33 2010 E33 E35
8. P.A. Schweizer, R. Becker, H.A. Katus, D. Thomas Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine Clin Res Cardiol 99 2010 467 470
9. B. Belhassen, A. Glick, S. Viskin Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome Pacing Clin Electrophysiol 32 2009 294 301
10. C. Antzelevitch, J.M. Fish Therapy for the Brugada syndrome Handb Exp Pharmacol 171 2006 305 330
11. T. Ohgo, H. Okamura, T. Noda et al. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation Heart Rhythm 4 2007 695 700
12. K. Kyriazis, E. Bahlmann, H. Van der Schalk, K.H. Kuck Electrical storm in Brugada syndrome successfully treated with orciprenaline: effect of low-dose quinidine on the electrocardiogram Europace 11 2009 665 666
13. M.F. Márquez, R. Allende, J.L. Morales Unmasking the Brugada syndrome with high parasternal leads Europace 9 2007 1216
14. A. Bonny, J. Tonet, G. Fontaine et al. Brugada syndrome in pure black Africans J Cardiovasc Electrophysiol 19 2008 421 426
15. P.G. Postema, C. Wolpert, A.S. Amin et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website Heart Rhythm 9 2009 1335 1341
16. H. Suzuki, K. Torigoe, O. Numata, S. Yazaki Infant case with a malignant form of Brugada syndrome J Cardiovasc Electrophysiol 11 2000 1277 1280
17. A. Watanabe, K.F. Kusano, H. Morita et al. Low dose quinidine test in patients with Brugada syndrome Heart Rhythm 2 2005 S266 abstr P5-39
18. Y. Mizusawa, H. Sakurada, M. Nishizaki, M. Hiraoka Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment J Cardiovasc Pharmacol 47 2006 359 364
19. V. Probst, S. Evain, V. Gournay et al. Monomorphic ventricular tachycardia due to Brugada syndrome successfully treated by hydroquinidine therapy in a 3-year-old child J Cardiovasc Electrophysiol 17 2006 97 100
20. E. Nakagawa, M. Takagi, H. Tatsumi, M. Yoshiyama Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome Circ J 72 2008 1025 1029
21. M.B. Sharif-Kazemi, Z. Emkanjoo, A. Tavoosi et al. Electrical storm in Brugada syndrome during pregnancy Pacing Clin Electrophysiol 34 2011 E18 E21
22. S. Mehrotra, R. Juneja, N. Naik, B.B. Pavri Successful use of quinine in the treatment of electrical storm in a child with Brugada syndrome J Cardiovasc Electrophysiol 22 2011 594 597
23. M.F. Márquez, G. Salica Hermosillo AG, Pastelín G, Cárdenas M. Drug therapy in Brugada syndrome Curr Drug Targets Cardiovasc Haematol Disord 5 2005 409 417
24. A.A. Wilde, P.G. Postema, J.M. Di Diego et al. The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization J Mol Cell Cardiol 49 2010 543 553
25. M.G. Hoogendijk, M. Potse, A. Vinet, J.M. de Bakker, R.S.T. Coronel segment elevation by current-to-load mismatch: an experimental and computational study Heart Rhythm 8 2011 111 118
26. R. Mendez, J. Aceves, E. Kabela Differences among quinidine, atropine and potassium in their action on experimental arrhythmias Acta Cardiol 20 1965 1 16
27. M. Alings, L. Dekker, A. Sadee et al. Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome Pacing Clin Electrophysiol 24 2001 1420 1422
28. H. Watanabe, M. Chinushi, T. Washizuka et al. Variable electrocardiographic effects of short-term quinidine sulfate administration in Brugada syndrome Pacing Clin Electrophysiol 28 2005 372 377
29. S. Sánchez-Pérez, G. Pastelín, B. Chávez, R. Méndez Tiempo de administración intravenosa de quinidina como factor determinante de sus efectos electrofisiológicos auriculares Arch Inst Cardiol Méx 50 1980 25 32
30. S. Viskin, A.A. Wilde, H.L. Tan, C. Antzelevitch, W. Shimizu, B. Belhassen Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry Heart Rhythm 6 2009 401 404
31. S. Viskin, C. Antzelevitch, M.F. Márquez, B. Belhassen Quinidine: a valuable medication joins the list of 'endangered species' Europace 9 2007 1105 1106
32. M. Chimienti, M.B. Regazzi, M.T. La Rovere et al. Comparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration Cardiovasc Drugs Ther 2 1988 679 686
33. S. Lévy, C. Moyal, E. Dolla et al. Comparison of the efficacy of two forms of long-acting hydroquinidine and quinidine in the prevention of pacing induced ventricular tachycardia Arch Mal Coeur Vaiss 86 1993 1359 1363
34. P. Delise, G. Allocca, E. Marras et al. Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach Eur Heart J 32 2011 169 176
35. V. Probst, C. Veltmann, L. Eckardt et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry Circulation 121 2010 635 643